Skip to main content

2017 Mintz & ML Strategies Pharmacy Industry Summit

Apr
5
2017

Date: April 5, 2017 - April 6, 2017

Time: 7:30AM - 10:00AM

Location: Washington, DC

Topics

  • Government Enforcement and the Pharmaceutical Industry
  • Drug Pricing Debate and Evolving Roles of Pharmacy Industry Players
  • Value-Based and Innovative Contracting and Reimbursement
  • State Issues Affecting the Pharmaceutical Industry
  • Congressional Panel
  • FDA’s Impact on the Supply Chain – Evolving Policies and Changing Priorities
  • Affordable Care Act Developments
  • Value-Based and Innovative Contracting and Reimbursement
  • Government Enforcement and the Pharmaceutical Industry
     

Our 2nd Annual Pharmacy Industry Summit will bring together stakeholders and thought leaders from across the industry to discuss legal and policy challenges facing manufacturers, PBMs, payors, pharmacies, and providers.

As legislative, agency, and enforcement priorities take shape under the new administration, we will consider the likelihood of success for various initiatives and the potential impact on the industry.

 

Register for Event

Speakers

Theresa advises clients on all aspects of the pharmaceutical supply chain, including counseling industry stakeholders on a range of business, legal, transactional, and compliance matters. She provides clients with strategic counseling and creative business modeling that considers legal restrictions and regulatory risk in light of innovation and business goals.
Professional Cropped Berson Susan Mintz

Susan W. Berson

Moderator

Moderator

Professional Cropped Hecht Alex Mintz

Alexander Hecht

Moderator

Alexander Hecht is Executive Vice President & Director of Operations of ML Strategies, Washington, DC. He's an attorney with over a decade of senior-level experience in Congress and trade associations. Alex helps clients with regulatory and legislative issues, including health care and technology.
Professional Cropped Hawana Joanne Mintz

Joanne S. Hawana

Moderator

Joanne counsels global clients on the regulatory and distribution-related implications when bringing a new FDA-regulated product to market and how to ensure continued compliance after a product is commercialized.

Moderator

Theresa advises clients on all aspects of the pharmaceutical supply chain, including counseling industry stakeholders on a range of business, legal, transactional, and compliance matters. She provides clients with strategic counseling and creative business modeling that considers legal restrictions and regulatory risk in light of innovation and business goals.

Panelist